{"resourceType":"ValueSet","id":"2.16.840.1.113883.3.3616.200.110.102.5093","meta":{"versionId":"5","lastUpdated":"2022-12-07T01:03:35.000-05:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"Clinical Architecture"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2023-06-21"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2022-12-07"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.3616.200.110.102.5093","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113883.3.3616.200.110.102.5093"}],"version":"20221207","name":"VolatileOrganicCompoundsAssociatedWithSARSCoV2Infection","title":"Volatile Organic Compounds Associated with SARS CoV 2 Infection","status":"retired","experimental":false,"date":"2023-06-21T18:16:37-04:00","publisher":"Clinical Architecture","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: This set of values contains terms related to),(Data Element Scope: ),(Inclusion Criteria: Includes),(Exclusion Criteria: Excludes)","compose":{"include":[{"system":"http://loinc.org","concept":[{"code":"100342-5","display":"Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry"}]}]},"expansion":{"identifier":"urn:uuid:c393a002-d89c-46dd-99a3-f85e9aedace3","timestamp":"2023-12-11T01:43:27-05:00","total":1,"contains":[{"system":"http://loinc.org","version":"2.76","code":"100342-5","display":"Volatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry"}]}}